Tech Company Financing Transactions
Metrion Biosciences Funding Round
Metrion Biosciences, based in Cambridge, England, secured $4.7 million in funding from Maven Capital Partners and Gresham House.
Transaction Overview
Company Name
Announced On
12/20/2023
Transaction Type
Venture Equity
Amount
$4,699,000
Round
Undisclosed
Investors
Maven Capital Partners (Lead Investor)
Proceeds Purpose
The company intends to use the funds to to further expand its laboratories in Cambridge, UK, invest in specialist equipment and enhance global marketing activities.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
First Floor, Granta Centre Great Abington
Cambridge, England, CB21 6AL
UK
Cambridge, England, CB21 6AL
UK
Phone
Website
Email Address
Overview
Metrion Biosciences is a specialist ion channel contract research organisation providing drug discovery services to pharmaceutical and bioscience customers worldwide. We provide a range of exceptional ion channel electrophysiology expertise and services. These services include high-quality, cost-effective compound screening assays, detailed characterisation of lead compounds in human cells and native tissue, as well as confirmation of efficacy in stem cell and other phenotypic models.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Andrew Southan
Chief Operating Officer
Robert Kirby
Chief Scientific Officer
Edward Stevens
Browse more venture capital transactions:
Prev: 12/20/2023: J.C. Flowers & Co. venture capital transaction
Next: 12/20/2023: FeelTect venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs